Dawar Consulting
This role focuses on oligonucleotide therapeutics discovery, supporting RNAi-based research through synthesis, characterization, and collaboration across therapeutic areas. The position involves designing and executing synthesis workflows, performing analytical characterization, and scaling up lead candidates for preclinical studies. The scientist will collaborate with cross-functional teams to integrate chemistry and biology data while maintaining lab equipment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dawar Consulting.
Scientist II – Oligonucleotide Synthesis
Dawar Consulting
Scientist/Sr Scientist - Oligonucleotide Chemistry
Eli Lilly and Company
Lilly Genetic Medicines (LGM) Team is looking for a collaborative, creative, and energetic problem solver to join a multidisciplinary team at the front edge of innovation. They will join our fast-paced, interdisciplinary team as we utilize novel RNA/oligonucleotide based therapeutic modalities to enhance the Lilly portfolio. The successful applicant will utilize their knowledge and technical expertise to accelerate the core capabilities of large-scale oligonucleotide synthesis of internal RNAi-based clinical candidates. Are you skilled in large-scale oligonucleotide synthesis and interested in learning about RNAi discovery and development for impactful patient therapies? We want you on our team!
Eli Lilly and Company
Temporary Research Associate / Scientist
iSi Environmental
Associate Oligonucleotide Chemist
Eli Lilly and Company
Senior Scientist, Oligo Chemistry
Leica Biosystems